Intramuscular Administration of Recombinant Adeno-Associated Virus 2 -1 Antitrypsin (rAAV-SERPINA1) Vectors in a Nonhuman Primate Model: Safety and Immunologic Aspects

By Song S.   Scott-Jorgensen M.   Wang J.   Poirier A.   Crawford J.   Campbell-Thompson M.   Flotte T.R.  

Molecular Therapy, Vol. 6, Iss. 3, 2002-09 ,pp. : 329-335

Elsevier

Access to resources Recommend Favorite

Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

By Fu H.   Muenzer J.   Samulski R.J.   Breese G.   Sifford J.   Zeng X.   McCarty D.M.  

Molecular Therapy, Vol. 8, Iss. 6, 2003-12 ,pp. : 911-917

Elsevier

Access to resources Recommend Favorite

Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques

By Fischer A.C.   Beck S.E.   Smith C.I.   Laube B.L.   Askin F.B.   Guggino S.E.   Adams R.J.   Flotte T.R.   Guggino W.B.  

Molecular Therapy, Vol. 8, Iss. 6, 2003-12 ,pp. : 918-926

Elsevier

Access to resources Recommend Favorite

Persistent phenotypic correction of central diabetes insipidus using adeno-associated virus vector expressing Arginine-Vasopressin in brattleboro rats

By Ideno J.   Mizukami H.   Honda K.   Okada T.   Hanazono Y.   Kume A.   Saito T.   Ishibashi S.   Ozawa K.  

Molecular Therapy, Vol. 8, Iss. 6, 2003-12 ,pp. : 895-902

Elsevier

Access to resources Recommend Favorite

Adeno-associated virus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor reduces atherosclerotic lesion formation in LDL receptor knockout mice

By Jalkanen J.   Leppanen P.   Pajusola K.   Narvanen O.   Mahonen A.   Vahakangas E.   Greaves D.R.   Bueler H.   Yla-Herttuala S.  

Molecular Therapy, Vol. 8, Iss. 6, 2003-12 ,pp. : 903-910

Elsevier

Access to resources Recommend Favorite